What Is MicRhoGAM? Uses, Dosage, and What You Need to Know in 2026

If you've been told you need "the Rh shot" after a miscarriage or early pregnancy loss, there's a good chance your provider prescribed MicRhoGAM. It's one of the most important — and least talked about — medications in early pregnancy care. This guide explains what MicRhoGAM is, who needs it, how it's given, and what makes it different from the more commonly known RhoGAM.

What Is MicRhoGAM?

MicRhoGAM (brand name for Rho(D) immune globulin human, mini-dose) is a biological medication made from human blood plasma. It contains concentrated IgG antibodies against the Rh(D) antigen — a protein found on red blood cells in Rh-positive individuals. MicRhoGAM is manufactured by Kedrion Biopharma Inc. and has been FDA-approved since 1968.

The "Micro" in MicRhoGAM refers to its mini-dose formulation: 50 micrograms (mcg) / 250 International Units (IU) per dose. This is distinct from the full-dose RhoGAM (300 mcg / 1500 IU), which is used later in pregnancy or postpartum.

What Is It Used For?

MicRhoGAM is FDA-approved to prevent Rh immunization in Rh-negative patients following:

Spontaneous abortion (miscarriage) at or before 12 weeks of gestation

Induced abortion (termination of pregnancy) at or before 12 weeks

Ectopic pregnancy at or before 12 weeks of gestation

Threatened abortion at or before 12 weeks

Transfusion of less than 2.5 mL of Rh-positive red blood cells into an Rh-negative individual

Who Needs MicRhoGAM?

MicRhoGAM is needed by Rh-negative individuals who are not already sensitized to the Rh(D) factor and have experienced one of the events above. About 15% of the population is Rh-negative (blood type that lacks the Rh(D) antigen). If you are Rh-negative and pregnant or recently pregnant, your provider should routinely check your Rh status.

MicRhoGAM is NOT needed if:

You are Rh-positive (already have the Rh(D) antigen on your blood cells)

You are already sensitized (already have anti-D antibodies from a prior sensitization event)

Both parents are Rh-negative (in which case the fetus cannot be Rh-positive)

How Is MicRhoGAM Given?

MicRhoGAM comes as a prefilled syringe containing a single dose of 50 mcg (250 IU). It is given as an intramuscular (IM) injection — typically into the deltoid muscle of the upper arm or the outer thigh. It cannot be given intravenously and cannot be self-administered. A healthcare professional must administer it.

Timing is critical: MicRhoGAM should be given within 72 hours of the at-risk event. For induced abortions, within 3 hours is preferred. The sooner it is given, the more reliably it prevents Rh sensitization.

MicRhoGAM vs. RhoGAM: What's the Difference?

Both MicRhoGAM and RhoGAM are made by Kedrion Biopharma and share the same FDA biologics license. The key difference is dose:

MicRhoGAM: 50 mcg / 250 IU — for first-trimester events (≤12 weeks gestation). Suppresses immune response to 2.5 mL of Rh-positive red blood cells.

RhoGAM: 300 mcg / 1500 IU — for second/third trimester, postpartum, and other higher-risk obstetric indications. Suppresses immune response to 15 mL of Rh-positive red blood cells.

The mini-dose is used for first-trimester events because fetal blood volume is very small at early gestational ages, meaning less anti-D is needed to prevent sensitization. Using the full dose is not harmful but is not necessary in these early cases when the mini-dose is available.

Storage and Handling

MicRhoGAM must be stored at 2 to 8°C (refrigerated). It must not be frozen. Do not use after the expiration date printed on the syringe. Handle as a biologic product with appropriate care.

For a deeper explanation of how MicRhoGAM works at the immune system level, read our guide: How Does MicRhoGAM Work? Mechanism of Action Explained. If you're having trouble finding MicRhoGAM near you, medfinder can help locate it at pharmacies near you.